In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Confer Health brings in $9.5mm in early round

Executive Summary

Confer Health Inc. (in-home, direct-to-consumer diagnostics) raised $9.5mm in an undisclosed early-stage round, assumed to be its Series A, led by Social Capital (added a board member).
Deal Industry
  • Biotechnology
  • In Vitro Diagnostics
    • Chemistry, Immunoassay
    • Saliva-based Testing
    • Urine-based Testing
  • Medical Devices
    • Consumables, Central Supplies
    • Diagnostic Equipment & Supplies
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies

Advertisement
UsernamePublicRestriction

Register